NYSE: ASAN

Asana, Inc.

CIK 0001477720 · SIC 7372 · Prepackaged Software

Mid Revenue $791M Assets $806M as of Aug 26, 2026

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (HPQ 10-Q) is open in full — no account needed.

8-K Filed Jul 17, 2026 · Period ending Jul 13, 2026

Asana's Chief Accounting Officer Veronica Sosa resigns, effective August 7

2 material changes detected. Sign up free to read the summary.

8-K Filed Jun 12, 2026 · Period ending Jun 8, 2026

Summary not yet generated.

Partner

Trade ASAN commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

10-Q Filed May 28, 2026 · Period ending Apr 30, 2026

revenue $205.1M, net income -$14.4M. Asana narrows loss 65%, launches AI agent product, acquires StackAI amid CEO transition

5 material changes detected. Sign up free to read the summary.

8-K Filed May 28, 2026 · Period ending May 28, 2026

Asana reports Q1 FY2027 earnings for quarter ended April 30, 2026

1 material change detected. Sign up free to read the summary.

8-K Filed Apr 20, 2026 · Period ending Apr 14, 2026

Asana board to shrink 30% as three directors resign in planned refreshment

3 material changes detected. Sign up free to read the summary.

10-K Filed Mar 13, 2026 · Period ending Jan 31, 2026

revenue $790.8M, net income -$189.0M. Asana narrows loss 26%, boosts buybacks 69%, launches AI products on consumption pricing

5 material changes detected. Sign up free to read the summary.

8-K Filed Mar 13, 2026 · Period ending Mar 10, 2026

Asana increases executive severance, adopts new bonus plan, promotes CAO

3 material changes detected. Sign up free to read the summary.

10-Q Filed Dec 2, 2025 · Period ending Oct 31, 2025

Summary not yet generated.

10-Q Filed Jun 3, 2025 · Period ending Apr 30, 2025

Summary not yet generated.

10-K Filed Mar 18, 2025 · Period ending Jan 31, 2025

Summary not yet generated.

Latest financial statements

From 10-Q filed May 28, 2026 (period ending Apr 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Condensed Consolidated Statements of Operations (Unaudited)

(in thousands, except per share amounts)

Description Three months ended April 30, 2026 Three months ended April 30, 2025
Revenues 205,095 187,267
Cost of revenues 25,414 19,227
Gross profit 179,681 168,040
Operating expenses:
Research and development 66,089 75,127
Sales and marketing 92,464 99,841
General and administrative 36,368 36,976
Total operating expenses 194,921 211,944
Loss from operations (15,240) (43,904)
Interest income and other income (expense), net 2,903 5,830
Interest expense (649) (791)
Loss before provision for income taxes (12,986) (38,865)
Provision for income taxes 1,419 1,153
Net loss (14,405) (40,018)
Net loss per share:
Basic and diluted (0.06) (0.17)
Weighted-average shares used in calculating net loss per share:
Basic and diluted 238,164 234,859

Condensed Consolidated Balance Sheets (Unaudited)

(in thousands)

Description April 30, 2026 January 31, 2026
Assets
Current assets
Cash and cash equivalents 193,656 199,835
Marketable securities 230,984 234,210
Restricted cash 696 418
Accounts receivable, net 73,483 110,312
Prepaid expenses and other current assets 51,664 48,573
Total current assets 550,483 593,348
Property and equipment, net 88,911 88,313
Operating lease right-of-use assets 136,236 133,422
Other assets 29,882 29,005
Total assets 805,512 844,088
Liabilities and Stockholders’ Equity
Current liabilities
Accounts payable 25,155 18,822
Accrued expenses and other current liabilities 105,559 123,716
Deferred revenue, current 322,931 333,636
Operating lease liabilities, current 25,999 24,846
Total current liabilities 479,644 501,020
Deferred revenue, noncurrent 187 220
Operating lease liabilities, noncurrent 183,944 183,749
Other liabilities 4,755 4,982
Total liabilities 668,530 689,971
Commitments and contingencies (Note 7)
Stockholders' equity
Common stock 2 2
Additional paid-in capital 2,343,418 2,299,616
Accumulated other comprehensive income 2,658 4,205
Accumulated deficit (2,209,096) (2,149,706)
Total stockholders’ equity 136,982 154,117
Total liabilities and stockholders’ equity 805,512 844,088

Condensed Consolidated Statements of Cash Flows (Unaudited)

(in thousands)

Description Three months ended April 30, 2026 Three months ended April 30, 2025
Cash flows from operating activities
Net loss (14,405) (40,018)
Adjustments to reconcile net loss to net cash provided by operating activities:
Allowance for expected credit losses 493 1,027
Depreciation and amortization 6,052 4,963
Amortization of deferred contract acquisition costs 6,836 6,691
Stock-based compensation expense 36,322 48,167
Net accretion of discount on marketable securities (255) (736)
Non-cash lease expense 4,910 4,540
Amortization of discount on revolving credit facility and term loan issuance costs 30 30
Changes in operating assets and liabilities:
Accounts receivable 36,462 18,738
Prepaid expenses and other current assets (10,055) (8,846)
Other assets (944) (714)
Accounts payable 7,354 (1,724)
Accrued expenses and other liabilities (15,464) (7,442)
Deferred revenue (10,738) (12,512)
Operating lease liabilities (6,354) (5,400)
Net cash provided by operating activities 40,244 6,764
Cash flows from investing activities
Purchases of marketable securities (50,043) (34,055)
Maturities of marketable securities 52,515 41,000
Purchases of property and equipment (2,808) (638)
Capitalized internal-use software costs (3,086) (2,131)
Net cash (used in) provided by investing activities (3,422) 4,176
Cash flows from financing activities
Repayment of term loan (2,500)
Repurchases of common stock (44,985) (14,526)
Proceeds from exercise of stock options 686 1,257
Proceeds from employee stock purchase plan 4,874 7,746
Net cash used in financing activities (41,925) (5,523)
Effect of foreign exchange rates on cash, cash equivalents, and restricted cash (798) 3,799
Net (decrease) increase in cash, cash equivalents, and restricted cash (5,901) 9,216
Cash, cash equivalents, and restricted cash
Beginning of period 200,253 184,864
End of period 194,352 194,080

Amounts as printed on the EDGAR/iXBRL face — (in thousands, except per share amounts); (in thousands). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗

View AI report for this filing